Synopsis
The Mumbai-based reclusive investor held nearly 4 per cent stake in Sequent Scientific till March 2018 and about 2.07 per cent in Strides Pharma till September 2017. This is Mankekar’s first major investment since September 2019. Shareholding data showed he has not owned over 1 per cent in any company since then.
Mumbai: Shivanand Mankekar, one of India’s richest individual investors, bought a 2.3 per cent stake in Solara Active Pharma Science worth Rs 135 crore on Monday. The company was formed by carving out the API (active pharmaceutical ingredient) business of Strides Pharma and merging it with the human API business of Sequent Scientific.
The Mumbai-based reclusive investor held nearly 4 per cent stake in Sequent Scientific till March 2018 and
- FONT SIZE
AbcSmall
AbcMedium
AbcLarge
Sign in to read the full article
You’ve got this Prime Story as a Free Gift
₹399/month
Monthly
PLAN
Billed Amount ₹399
₹208/month
(Save 49%)
Yearly
PLAN
Billed Amount ₹2,499
15
Days Trial
+Includes DocuBay and TimesPrime Membership.
₹150/month
(Save 63%)
2-Year
PLAN
Billed Amount ₹3,599
15
Days Trial
+Includes DocuBay and TimesPrime Membership.
Already a Member? Sign In now
Why ?
Sharp Insight-rich, Indepth stories across 20+ sectors
Access the exclusive Economic Times stories, Editorial and Expert opinion
Clean experience with
Minimal AdsComment & Engage with ET Prime community Exclusive invites to Virtual Events with Industry Leaders A trusted team of Journalists & Analysts who can best filter signal from noise
